All Stories

  1. Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities
  2. Alternative approaches to lymphoedema care in lymphatic filariasis
  3. Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells
  4. Species differences in hepatic biotransformation of the anthelmintic drug flubendazole
  5. Chemotherapy in the treatment, control, and elimination of human onchocerciasis
  6. Detection of Circulating Parasite-Derived MicroRNAs in Filarial Infections
  7. Filarial Excretory-Secretory Products Induce Human Monocytes to Produce Lymphangiogenic Mediators
  8. Addressing the current challenges to finding new anthelminthic drugs
  9. Elimination of onchocerciasis from Africa: possible?
  10. Importance of ivermectin to human onchocerciasis: past, present, and the future
  11. Erythropoietin for treating post-ivermectin Loa-related serious adverse events?
  12. Efficacy of ivermectin against Onchocerca volvulus in Ghana
  13. Where next with Loa loa encephalopathy? Data are badly needed
  14. Human onchocerciasis: the essential partnership between research and disease control efforts
  15. Medical achievements under civil war conditions
  16. Hazards of the dental drill
  17. Onchocerciasis and Lymphatic Filariasis
  18. Svane localisation of non-palpable breast lesions